Here are five highlights:
1. Dr. Mobbs implanted the disc at Prince of Wales Private Hospital on April 28.
2. The patient had a degenerative cervical disc at level C6-C7.
3. The AxioMed viscoelastic disc is designed to restore disc height, lordosis, stability and motion of the spine.
4. Australia’s Therapeutic Goods Administration approved the company’s viscoelastic cervical and lumbar Freedom total disc replacement devices in 2016.
5. KICVentures acquired AxioMed in 2014, but AxioMed still owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.
More articles on devices:
Stryker releases video series featuring Jerome Bettis, Fred Funk
5 top global bone cement market players
North American artificial disc replacement market to double by 2023, hitting $614.5M — 7 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
